BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17183612)

  • 1. FOXP3: not just for regulatory T cells anymore.
    Ziegler SF
    Eur J Immunol; 2007 Jan; 37(1):21-3. PubMed ID: 17183612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired T cell receptor signaling in Foxp3+ CD4 T cells.
    Carson BD; Ziegler SF
    Ann N Y Acad Sci; 2007 Apr; 1103():167-78. PubMed ID: 17376831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CD4+ CD25+ regulatory T cell suppressor function by analogs of the selecting peptide.
    Larkin J; Picca CC; Caton AJ
    Eur J Immunol; 2007 Jan; 37(1):139-46. PubMed ID: 17154263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive.
    Noël G; Brinster C; Semana G; Bruniquel D
    Int Immunol; 2009 Sep; 21(9):1025-36. PubMed ID: 19625380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death.
    Kasprowicz DJ; Droin N; Soper DM; Ramsdell F; Green DR; Ziegler SF
    Eur J Immunol; 2005 Dec; 35(12):3424-32. PubMed ID: 16285010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells.
    Bodor J; Fehervari Z; Diamond B; Sakaguchi S
    Eur J Immunol; 2007 Apr; 37(4):884-95. PubMed ID: 17372992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP3 modifies the phenotypic and functional properties of regulatory T cells.
    Campbell DJ; Ziegler SF
    Nat Rev Immunol; 2007 Apr; 7(4):305-10. PubMed ID: 17380159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
    Ono M; Yaguchi H; Ohkura N; Kitabayashi I; Nagamura Y; Nomura T; Miyachi Y; Tsukada T; Sakaguchi S
    Nature; 2007 Apr; 446(7136):685-9. PubMed ID: 17377532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties.
    Merlo A; Tagliabue E; Mènard S; Balsari A
    Immunol Lett; 2008 Apr; 117(1):106-13. PubMed ID: 18295349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells.
    Blache C; Adriouch S; Calbo S; Drouot L; Dulauroy S; Arnoult C; Le Corre S; Six A; Seman M; Boyer O
    J Immunol; 2009 Oct; 183(7):4182-6. PubMed ID: 19767568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells.
    Dumitriu IE; Dunbar DR; Howie SE; Sethi T; Gregory CD
    J Immunol; 2009 Mar; 182(5):2795-807. PubMed ID: 19234174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.
    Saruta M; Yu QT; Fleshner PR; Mantel PY; Schmidt-Weber CB; Banham AH; Papadakis KA
    Clin Immunol; 2007 Dec; 125(3):281-90. PubMed ID: 17897887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the transcription factor Foxp3 in the development of regulatory T cells.
    Kim JM; Rudensky A
    Immunol Rev; 2006 Aug; 212():86-98. PubMed ID: 16903908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.
    Crellin NK; Garcia RV; Levings MK
    J Immunol Methods; 2007 Jul; 324(1-2):92-104. PubMed ID: 17582431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.